BMJ  1991;302:555-560 (9 March), doi:10.1136/bmj.302.6776.555

SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.

OBJECTIVE--To see whether early elective angiography with a view to coronary angioplasty or bypass grafting of a stenosed infarct related vessel would improve outcome in acute myocardial infarction treated by thrombolysis with anistreplase. DESIGN--Randomised study of two treatment strategies with analysis of results over 12 months. SETTING--21 district hospitals and regional cardiac centres in Britain and Ireland. SUBJECTS--800 of 993 patients presenting with clinical and electrocardiographic features of acute myocardial infarction up to three hours after the onset of major symptoms. TREATMENT STRATEGIES--Intravenous anistreplase 30 units followed by a standard regimen of heparin, warfarin, and timolol and (in patients so randomised) early angiography plus appropriate intervention. MAIN OUTCOME MEASURE--Death or reinfarction within 12 months. RESULTS--397 patients were randomised to receive early angiography plus appropriate intervention (coronary angioplasty in 169 cases, coronary grafting in 59) and 403 patients to receive conservative care (of these, 12 had angioplasty and seven bypass grafting during the initial admission). By 12 months mortality (5.8% (23 patients) in the intervention group v 5.0% (20) in the conservative care group; p = 0.6) and rates of reinfarction (15.1% (60 patients) v 12.9% (52); p = 0.4) were similar in the two groups. No significant differences in rates of angina or rest pain were found at 12 months. Left ventricular ejection fraction at three and 12 months was the same in both groups. Median hospital stay was longer in the intervention group (11 days v 10 days; p less than 0.0001). CONCLUSION--For most patients given thrombolytic treatment for acute myocardial infarction a strategy of angiography and intervention is appropriate only when required for clinical indications.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Stone, G. W. (2008). Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions. Circulation 118: 552-566 [Full text]  
• O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S. (2008). Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-analysis. JAMA 300: 71-80 [Abstract] [Full text]  
• Kiernan, T. J., Ting, H. H., Gersh, B. J. (2007). Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls. Eur Heart J 28: 1545-1553 [Abstract] [Full text]  
• Bavry, A. A., Kumbhani, D. J., Rassi, A. N., Bhatt, D. L., Askari, A. T. (2006). Benefit of Early Invasive Therapy in Acute Coronary Syndromes: A Meta-Analysis of Contemporary Randomized Clinical Trials. J Am Coll Cardiol 48: 1319-1325 [Abstract] [Full text]  
• Collet, J.-P., Montalescot, G., Le May, M., Borentain, M., Gershlick, A. (2006). Percutaneous Coronary Intervention After Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy. J Am Coll Cardiol 48: 1326-1335 [Abstract] [Full text]  
• Mehta, S. R., Cannon, C. P., Fox, K. A. A., Wallentin, L., Boden, W. E., Spacek, R., Widimsky, P., McCullough, P. A., Hunt, D., Braunwald, E., Yusuf, S. (2005). Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes: A Collaborative Meta-analysis of Randomized Trials. JAMA 293: 2908-2917 [Abstract] [Full text]  
• Danchin, N. (2005). Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?. Eur Heart J 26: 529-531 [Full text]  
• Gersh, B. J., Stone, G. W., White, H. D., Holmes, D. R. Jr (2005). Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future?. JAMA 293: 979-986 [Abstract] [Full text]  
• Antman, E. M., Van de Werf, F. (2004). Pharmacoinvasive Therapy: The Future of Treatment for ST-Elevation Myocardial Infarction. Circulation 109: 2480-2486 [Full text]  
• Weintraub, W. S., Sadanandan, S. (2003). Percutaneous Coronary Intervention in Stable Patients After Acute Myocardial Infarction. Circulation 108: 1292-1294 [Full text]  
• Zeymer, U., Uebis, R., Vogt, A., Glunz, H.-G., Vohringer, H.-F., Harmjanz, D., Neuhaus, K.-L. (2003). Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease: A Study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation 108: 1324-1328 [Abstract] [Full text]  
• Gupta, M., Chang, W.-C., Van de Werf, F., Granger, C. B., Midodzi, W., Barbash, G., Pehrson, K., Oto, A., Toutouzas, P., Jansky, P., Armstrong, P. W., for the ASSENT II Investigators, (2003). International differences in in-hospital revascularization and outcomes following acute myocardial infarction: A multilevel analysis of patients in ASSENT-2. Eur Heart J 24: 1640-1650 [Abstract] [Full text]  
• Dauerman, H. L. (2003). The early days after ST-segment elevation acute myocardial infarction: Reconsidering the delayed invasive approach. J Am Coll Cardiol 42: 420-423 [Full text]  
• Gabriel Steg, P., Iung, B., Feldman, L. J, Maggioni, A. P, Keil, U., Deckers, J., Cokkinos, D., Fox, K. A.A, for the ENACT investigators, (2003). Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT. Eur Heart J 24: 613-622 [Abstract] [Full text]  
• The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W. (2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24: 28-66 [Full text]  
• Ronner, E., van Domburg, R.T., van den Brand, M.J.B.M., de Feyter, P.J., Foley, D.P., van der Giessen, W.J., Serruys, P.W., Simoons, M.L. (2002). Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies. A single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. Eur Heart J 23: 1529-1537 [Abstract] [Full text]  
• Yousef, Z. R., Redwood, S. R., Bucknall, C. A., Sulke, A. N., Marber, M. S. (2002). Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: Results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 40: 869-876 [Abstract] [Full text]  
• Llevadot, J, Giugliano, R.P, Antman, E.M, Wilcox, R.G, Gurfinkel, E.P, Henry, T, McCabe, C.H, Charlesworth, A, Thompson, S, Nicolau, J.C, Tebbe, U, Sadowski, Z, Braunwald, E, for the InTIME II Invatigators, (2001). Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J 22: 2104-2115 [Abstract]  
• Smith, S. C. Jr, Dove, J. T., Jacobs, A. K., Ward Kennedy, J., Kereiakes, D., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., Gibbons, R. J., Alpert, J. P., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr (2001). ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 37: 2239-2239 [Full text]  
• Rogers, W. J., Canto, J. G., Lambrew, C. T., Tiefenbrunn, A. J., Kinkaid, B., Shoultz, D. A., Frederick, P. D., Every, N., for the Investigators in the National Registry of, (2000). Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36: 2056-2063 [Abstract] [Full text]  
• Herrmann, H. C., Moliterno, D. J., Ohman, E. M., Stebbins, A. L., Bode, C., Betriu, A., Forycki, F., Miklin, J. S., Bachinsky, W. B., Lincoff, A. M., Califf, R. M., Topol, E. J. (2000). Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial. J Am Coll Cardiol 36: 1489-1496 [Abstract] [Full text]  
• Widimsky, P., Groch, L., Zelizko, M., Aschermann, M., Bednar, F., Suryapranata, H. (2000). Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur Heart J 21: 823-831 [Abstract]  
• Marrugat, J, Ferrieres, J, Masia, R, Ruidavets, J, Sala, J (2000). Differences in use of coronary angiography and outcome of myocardial infarction in Toulouse (France) and Gerona (Spain). Eur Heart J 21: 740-746 [Abstract]  
• Ross, A. M., Coyne, K. S., Reiner, J. S., Greenhouse, S. W., Fink, C., Frey, A., Moreyra, E., Traboulsi, M., Racine, N., Riba, A. L., Thompson, M. A., Rohrbeck, S., Lundergan, C. F., for the PACT Investigators, (1999). A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol 34: 1954-1962 [Abstract] [Full text]  
• Scanlon, P. J., Faxon, D. P., Audet, A.-M., Carabello, B., Dehmer, G. J., Eagle, K. A., Legako, R. D., Leon, D. F., Murray, J. A., Nissen, S. E., Pepine, C. J., Watson, R. M., Ritchie, J. L., Gibbons, R. J., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Russell, R. O. Jr, Ryan, T. J., Smith, S. C. Jr (1999). ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33: 1756-1824 [Full text]  
• Van de Werf, F., Topol, E. J., Lee, K. L., Woodlief, L. H., Granger, C. B., Armstrong, P. W., Barbash, G. I., Hampton, J. R., Guerci, A., Simes, R. J., Ross, A. M., Califf, R. M., the GUSTO Investigators, (1995). Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial. JAMA 273: 1586-1591 [Abstract]  
• Barbash, G. I., White, H. D., Modan, M., Diaz, R., Hampton, J. R., Heikkila, J., Kristinsson, A., Moulopoulos, S., Paolasso, E. A. C., Van der Werf, T., Pehrsson, K., Sandoe, E., Simes, J., Wilcox, R. G., Verstraete, M., von der Lippe, G., Van de Werf, F. (1994). Outcome of Thrombolytic Therapy in Relation to Hospital Size and Invasive Cardiac Services. Arch Intern Med 154: 2237-2242 [Abstract]  
• Lux, D. P. (1992). Social and Economic Factors in Patients With Coronary Disease. JAMA 268: 196-197 [Abstract]  
• Topol, E. J., Holmes, D. R., Rogers, W. J. (1991). Coronary Angiography after Thrombolytic Therapy for Acute Myocardial Infarction. ANN INTERN MED 114: 877-885 [Abstract]  

Online poll

Find out more here>> and here>>